Belinda Gray et al. JCHF 2013;1:

Slides:

Advertisements

Similar presentations

Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.

Advertisements

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Effect of Intermittent Atrial Tachyarrhythmia.

Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Predictors of Implantable Cardioverter-Defibrillator.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantable Cardioverter-Defibrillators at End of.

Date of download: 7/9/2016 From: Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac.

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Wearable Cardioverter-Defibrillator Use in Patients.

Date of download: 7/10/2016 From: Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

American College of Cardiology Presented by Dr. Stuart J. Connolly

Stephen W. Waldo et al. JACC 2008;51:

Tom F. Brouwer et al. JACEP 2016;2:89-96

DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)

José L. Morales et al. JACEP 2017;j.jacep

Tom F. Brouwer et al. JACEP 2016;2:

Kenshi Hayashi et al. JACEP 2016;2:

David D. Berg et al. JACC 2018;71:

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Caroline Zotter-Tufaro et al. JCHF 2015;3:

Tom F. Brouwer et al. JACEP 2016;2:

David F. Katz et al. JACEP 2016;j.jacep

Mintu P. Turakhia et al. JACEP 2016;2:

Volume 11, Issue 2, Pages (February 2014)

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Federico Migliore et al. JACEP 2016;2:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Prabhat Kumar et al. JACEP 2016;j.jacep

Mintu P. Turakhia et al. JACEP 2016;2:

Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.

K.R. Julian Chun et al. JACEP 2017;3:

Jordan B. King et al. JCHF 2016;4:

G. Michael Felker et al. JCHF 2014;2:

Svend A. Mortensen et al. JCHF 2014;2:

Prabhat Kumar et al. JACEP 2016;j.jacep

Yoshitaka Kimura et al. JACEP 2016;2:

Ivan C. Gerling et al. JCHF 2013;1:

Kenshi Hayashi et al. JACEP 2016;2:

David F. Katz et al. JACEP 2017;3:20-28

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

P. Michael Grossman et al. JCIN 2009;2:

Gordon R. Reeves et al. JCHF 2017;j.jchf

William T. Abraham et al. JCHF 2015;3:

Peter E. Carson et al. JCHF 2015;3:

Jerry D. Estep et al. JCHF 2013;1:

Emilce Trucco et al. JACEP 2018;j.jacep

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Matthew M. Zipse et al. JACEP 2015;1:94-102

Volume 8, Issue 3, Pages (March 2011)

Jordan S. Leyton-Mange et al. JACEP 2017;j.jacep

John Rickard et al. JCHF 2013;1:

Jeffrey B. Geske et al. JCHF 2018;j.jchf

Figure 1 Patient selection

Leo F. Buckley et al. JCHF 2016;4:1-8

Natasha A. Loghmanpour et al. JCHF 2016;4:

Khadijah Breathett et al. JCHF 2017;5:

Connie W. Tsao et al. JCHF 2016;4:

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Saadia Sherazi et al. JACEP 2015;1:74-80

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Results of comparisons of treatments in the network.

Khadijah Breathett et al. JCHF 2017;5:

Constantijn Franssen et al. JCHF 2016;4:

Dennis M. McNamara et al. JCHF 2014;2:

Zeenat Safdar et al. JCHF 2014;2:

Jeffrey Senfield et al. JACEP 2017;3:

Orly Vardeny et al. JCHF 2016;4:

Maria R. Costanzo et al. JCHF 2016;4:

Gianluigi Savarese et al. JCHF 2016;4:

(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.

Presentation transcript:

Belinda Gray et al. JCHF 2013;1:149-155 Proportion of Risk Factors Predicting Appropriate ICD Therapy The proportion of patients who experienced at least 1 appropriate implantable cardioverter defibrillator (ICD) event was significantly greater in the subgroup with 2 or more risk factors for sudden cardiac death (SCD)/indication for ICD compared to the subgroup with 1 risk factor/indication (43% vs. 22%; p = 0.027). Belinda Gray et al. JCHF 2013;1:149-155 American College of Cardiology Foundation